Evidence map›Paper›PMID 36769168›Full record

ArticleInternational journal of molecular sciences2023

Toll-like Receptor 2 Mediates VEGF Overexpression and Mesothelial Hyperpermeability in Tuberculous Pleural Effusion.

Wei-Lin Chen, Kai-Ling Lee, Kevin S Lai, Jie-Heng Tsai, Shih-Hsin Hsiao, Chi-Li Chung

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Biochemistry and biophysics reports · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wei-Lin ChenDepartment of Nursing, MacKay Junior College of Medicine, Nursing, and Management, Taipei 112, Taiwan.
Kai-Ling LeeGraduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
Kevin S LaiGraduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
Jie-Heng TsaiSchool of Respiratory Therapy, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
Shih-Hsin HsiaoDivision of Pulmonary Medicine, Department of Internal Medicine, Taipei Medical University Hospital, Taipei 110, Taiwan.
Chi-Li ChungDivision of Pulmonary Medicine, Department of Internal Medicine, Taipei Medical University Hospital, Taipei 110, Taiwan.ORCID 0000-0003-0656-976X

Funding

Ministry of Science and Technology of Taiwan MOST 107-2314-B-436-001, 109-2314-B-038-095-MY3
6 · The paper itself

Abstract

Toll-like receptor (TLR) is essential for the immune response to

Indexed as

Pleural EffusionTuberculosisHumansToll-Like Receptor 2Vascular Endothelial Growth Factor AVascular Endothelial Growth FactorsToll-Like Receptor 2Vascular Endothelial Growth Factor AVascular Endothelial Growth FactorsMycobacterium tuberculosispleural effusionpleural mesothelial cellpleural mesothelial permeabilityToll-like receptortuberculous pleural effusionvascular endothelial growth factorzonula occludens

Identifiers

PMID36769168
PMCPMC9918151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.